Angiotensin receptor blockers do not have an advantage over angiotensin-converting inhibitors [corrected].
Harman-Boehm
Ilana
I
Department of Internal Medicine C and Diabetes Unit, Soroka University Medical Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel. ilanahb@bgumail.bgu.ac.il
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D003928:Diabetic Nephropathies / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D006973:Hypertension / Q000150:complications; D011507:Proteinuria / Q000188:drug therapy; D016032:Randomized Controlled Trials as Topic
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors